Cite
HARVARD Citation
Van Oekelen, O. et al. (2020). A phase II study of pomalidomide, daily oral cyclophosphamide, and dexamethasone in relapsed/refractory multiple myeloma. Leukemia & lymphoma. 61 (9), pp. 2208-2215. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Van Oekelen, O. et al. (2020). A phase II study of pomalidomide, daily oral cyclophosphamide, and dexamethasone in relapsed/refractory multiple myeloma. Leukemia & lymphoma. 61 (9), pp. 2208-2215. [Online].